GH1 and obesity disorder: Additionally, mice with diet-induced obesity/steatosis exhibit reduced circulating GH levels [22,33], where GH treatment or elevation in endogenous GH [203,204,205] or GH-signaling due to the loss of SOCS2 [206] decreases diet-induced steatosis.